Working… Menu

A Randomized, Placebo-controlled Phase II Clinical Trial to Evaluate the Safety and Efficacy of F8IL10 (Dekavil) in Patients With Active RA Receiving MTX

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02270632
Recruitment Status : Unknown
Verified October 2016 by Philogen S.p.A..
Recruitment status was:  Recruiting
First Posted : October 21, 2014
Last Update Posted : November 28, 2016
Information provided by (Responsible Party):
Philogen S.p.A.

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : April 2018
Estimated Study Completion Date : April 2018